MK-3475 Clinical Trials
2 recruitingDrug
Phase 22
Showing 1–2 of 2 trials
Recruiting
Phase 2
Pembrolizumab and EV With Radiation Therapy for MIBC Patients (PEVRAD)
Bladder Cancer
Kyoto University Hospital30 enrolled4 locationsNCT05879653
Recruiting
Phase 2
First-line CBDCA/PTX/LEN/Pembrolizumab Combination for Previously Untreated Advanced or Recurrent Thymic Carcinomas (Artemis)
Untreated Advanced or Recurrent Thymic Carcinomas
National Cancer Center, Japan35 enrolled1 locationNCT05832827